NTVO - jaargang 21, nummer 3, juli 2024
dr. R.A.G. van Eerden
Op 7 juli 2023 promoveerde Ruben Alexander Georg van Eerden aan de Erasmus Universiteit Rotterdam op zijn proefschrift getiteld ‘Individualized dosing strategies for oncolytic agents and intratumoral pharmacokinetics’. Prof. dr. R.H.J. Mathijssen (afdeling Interne Oncologie, Erasmus MC Kankerinstituut) was zijn promotor. Copromotor was dr. S.L.W. Koolen (post-doctoraal onderzoeker binnen het translationele farmacologielaboratorium van de afdeling Interne Oncologie en ziekenhuisapotheker, Erasmus MC). De belangrijkste bevindingen uit het proefschrift worden hieronder kort beschreven.
(NED TIJDSCHR ONCOL 2024;21:129–31)
Lees verder
Naar boven
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
